Determining the fraction of pharmaceutical residues in wastewater originating from a hospital.

Pharmaceutical residues in water are frequently analysed and discussed in connection with sewage treatment, ecotoxicity and, natural and drinking water quality. Among different localities hospitals are suspected, or implied, to be a major and highly variable source of pharmaceuticals that substantially contribute to the total wastewater load. In this study, the contribution of pharmaceuticals from a hospital to a sewage treatment plant (STP) serving around 45,000 inhabitants was evaluated. Approximately 200 hospital beds result in a hospital bed density of 4.4 beds per 1000 inhabitants, which is a typical value for developed world countries. Prior to sampling, a sound systems analysis was performed, and a sophisticated continuous flow-proportional sampling regime was applied. Hence, overall experimental uncertainty was reduced to a minimum, and measurements provide clear evidence that, for 28 of 59 investigated substances, over 85% of the pharmaceutical residue loads do not originate from the hospital when applying a conservative error estimation. Only for 2 substances, trimethoprim (18%) and roxithromycin (56%), was the maximum observed contribution of the hospital >15%. On average, the contribution of the hospital for the compounds detected in both, hospital effluent and sewage treatment plant influent was small and fairly constant. Five compounds were only detected in hospital wastewater, and 24 neither in the hospital wastewater nor in the total wastewater at the influent of the STP. For these compounds no experimental contribution could be calculated. For the compounds where audit data for both the national consumption and the specific hospital under investigation were available, a prediction of the fraction of pharmaceuticals originating from the hospital was performed. Three quarters of the compounds, classified with the existing audit data, were in the same "hospital contribution category" as determined by measurements. For most of the other compounds, plausible reasons could be identified to explain the observed deviations.

[1]  Martin Schlabach,et al.  Source to sink tracking of selected human pharmaceuticals from two Oslo city hospitals and a wastewater treatment works. , 2007, Journal of environmental monitoring : JEM.

[2]  Y. Perrodin,et al.  Daily physicochemical, microbiological and ecotoxicological fluctuations of a hospital effluent according to technical and care activities. , 2008, The Science of the total environment.

[3]  K. Kümmerer Resistance in the environment. , 2004, The Journal of antimicrobial chemotherapy.

[4]  W Verstraete,et al.  The treatment of hospital wastewater: an appraisal. , 2006, Journal of water and health.

[5]  Christoph Ort,et al.  Mass flows of X-ray contrast media and cytostatics in hospital wastewater. , 2009, Environmental science & technology.

[6]  K Kümmerer,et al.  Drugs in the environment: emission of drugs, diagnostic aids and disinfectants into wastewater by hospitals in relation to other sources--a review. , 2001, Chemosphere.

[7]  S. Zuehlke,et al.  Occurrence, fate and assessment of polar metamizole (dipyrone) residues in hospital and municipal wastewater. , 2008, Chemosphere.

[8]  Bernd Heinzmann,et al.  Decentralized collection of iodinated x-ray contrast media in hospitals-results of the feasibility study and the practice test phase. , 2008, Water science and technology : a journal of the International Association on Water Pollution Research.

[9]  Sunil Kumar,et al.  Preliminary study of physico-chemical treatment options for hospital wastewater. , 2007, Journal of environmental management.

[10]  D. J. Brus,et al.  Sampling for Natural Resource Monitoring , 2006 .

[11]  S. Costanzo,et al.  The occurrence of antibiotics in an urban watershed: from wastewater to drinking water. , 2009, The Science of the total environment.

[12]  M. Fuerhacker,et al.  Genotoxic effects of wastewater from an oncological ward. , 2009, Mutation research.

[13]  W Gujer,et al.  Sampling for representative micropollutant loads in sewer systems. , 2006, Water science and technology : a journal of the International Association on Water Pollution Research.

[14]  Thomas Heberer,et al.  Contribution of effluents from hospitals and private households to the total loads of diclofenac and carbamazepine in municipal sewage effluents--modeling versus measurements. , 2005, Journal of hazardous materials.

[15]  Stuart J Khan,et al.  Modelling of pharmaceutical residues in Australian sewage by quantities of use and fugacity calculations. , 2004, Chemosphere.

[16]  F. Baquero,et al.  Antibiotics and antibiotic resistance in water environments. , 2008, Current opinion in biotechnology.

[17]  Alfredo C. Alder,et al.  Identification of fluoroquinolone antibiotics as the main source of umuC genotoxicity in native hospital wastewater , 1998 .

[18]  W. Bursch,et al.  Monitoring, removal and risk assessment of cytostatic drugs in hospital wastewater. , 2007, Water science and technology : a journal of the International Association on Water Pollution Research.

[19]  Klaus Kümmerer,et al.  Antibiotics in the aquatic environment--a review--part I. , 2009, Chemosphere.